- Home
- PULM vs IZEA Comparison
PULM vs IZEA Comparison
Compare PULM & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- IZEA
- Stock Information
- Founded
- PULM 2003
- IZEA 2006
- Country
- PULM United States
- IZEA United States
- Employees
- PULM N/A
- IZEA N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- IZEA Advertising
- Sector
- PULM Health Care
- IZEA Consumer Discretionary
- Exchange
- PULM Nasdaq
- IZEA Nasdaq
- Market Cap
- PULM 33.2M
- IZEA 29.1M
- IPO Year
- PULM N/A
- IZEA N/A
- Fundamental
- Price
- PULM $6.53
- IZEA $2.61
- Analyst Decision
- PULM
- IZEA
- Analyst Count
- PULM 0
- IZEA 0
- Target Price
- PULM N/A
- IZEA N/A
- AVG Volume (30 Days)
- PULM 63.0K
- IZEA 39.3K
- Earning Date
- PULM 08-12-2025
- IZEA 08-13-2025
- Dividend Yield
- PULM N/A
- IZEA N/A
- EPS Growth
- PULM N/A
- IZEA N/A
- EPS
- PULM N/A
- IZEA N/A
- Revenue
- PULM $1,921,000.00
- IZEA $36,896,490.00
- Revenue This Year
- PULM N/A
- IZEA $22.24
- Revenue Next Year
- PULM $134.88
- IZEA N/A
- P/E Ratio
- PULM N/A
- IZEA N/A
- Revenue Growth
- PULM N/A
- IZEA 7.17
- 52 Week Low
- PULM $1.78
- IZEA $1.68
- 52 Week High
- PULM $10.40
- IZEA $3.15
- Technical
- Relative Strength Index (RSI)
- PULM 41.09
- IZEA 47.64
- Support Level
- PULM $6.51
- IZEA $2.54
- Resistance Level
- PULM $7.00
- IZEA $2.76
- Average True Range (ATR)
- PULM 0.89
- IZEA 0.14
- MACD
- PULM -0.16
- IZEA -0.03
- Stochastic Oscillator
- PULM 44.16
- IZEA 31.52
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.